IL SB2131 | 2015-2016 | 99th General Assembly
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on May 6 2015 - 25% progression, died in committee
Action: 2015-05-06 - Referred to Assignments
Pending: Senate Assignments Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on May 6 2015 - 25% progression, died in committee
Action: 2015-05-06 - Referred to Assignments
Pending: Senate Assignments Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Amends the Pharmacy Practice Act. Provides that pharmacists may not interchange an atypical anti-psychotic drug or targeted immune modulator without notification and documented consent by the prescribing practitioner and the patient or patient's parent, legal guardian, or spouse. Provides that if the pharmacist does substitute a drug, then the pharmacist shall provide written notice to the patient no later than the time the prescription is dispensed. Provides that these provisions shall not be construed to prohibit generic drug substitution as provided for in the Pharmacy Practice Act. Effective immediately.
Title
PHARMACY-DRUG SUBSTITUTION
Sponsors
History
Date | Chamber | Action |
---|---|---|
2015-05-06 | Senate | Referred to Assignments |
2015-05-06 | Senate | First Reading |
2015-05-06 | Senate | Filed with Secretary by Sen. Dan Kotowski |
Code Citations
Chapter | Article | Section | Citation Type | Statute Text |
---|---|---|---|---|
225 | 85 | 26 | Amended Code | Citation Text |
Illinois State Sources
Type | Source |
---|---|
Summary | https://www.ilga.gov/legislation/BillStatus.asp?DocNum=2131&GAID=13&DocTypeID=SB&SessionID=88&GA=99 |
Text | https://www.ilga.gov/legislation/99/SB/09900SB2131.htm |